Are you or your loved ones suffering from advanced solid tumors?

You may be eligible to participate in a advanced solid tumors clinical trial.

Are you or your loved ones suffering from advanced solid tumors? You may be eligible to participate in a advanced solid tumors clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Solid Tumors in Philadelphia PA
NCT02609230 | Phase 1 | Interventional

Are you or your loved ones suffering from advanced solid tumors?

You may be eligible to participate in a advanced solid tumors clinical trial.

Are you or your loved ones suffering from advanced solid tumors? You may be eligible to participate in a advanced solid tumors clinical trial.

Recruiting

Male & Female

18 +

years old

This study is looking to recruit 54 Participants

This study will determine the maximum tolerated dose (MTD) and/or the recommended phase II dose (RP2D) of single agent ONC201 in patients with advanced solid tumors or multiple myeloma.

Where you'll go

Selected location

Interested in participating?
Selected location

Fox Chase Cancer Center Philadelphia

Philadelphia, PA, USA 19111-2497

Anthony Olszanski, MD 215-728-6900
Anthony.Olszanski@fccc.edu


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.